Partner Headlines - CPHD

  1. Benzinga's Top Upgrades

    Benzinga
  2. Bank of America Upgrades Cepheid To Buy

    Benzinga
  3. UPDATE: Citigroup Reiterates On Cepheid Following Positive Data

    Benzinga
  4. Top Medical Stocks: Cepheid Diagnostics Sales Strong

    IBD
  5. Cepheid Receives FDA Clearance For Xpert Norovirus, The First ...

    Benzinga
  6. CEPHEID

    IBD
  7. Cepheid Receives FDA Clearance For Xpert Flu/RSV XC

    Benzinga
  8. Cepheid To Develop Xpert Ebola For Countries Worst Hit By Epidemic

    Benzinga
  9. Several Sectors Emerge As Leaders Of New Market Uptrend

    IBD
  10. Stocks Fight Back To Finish Mixed

    IBD
  11. Dow, Nasdaq Battle Near Flat Line; Energy Weighs On S&P 500

    IBD
  12. Cepheid Explores Test For Ebola Disease; Q3 Beats

    IBD
  13. CEPHEID

    IBD
  14. Cepheid Extends Reach Of Direct US Commercial Operations

    Benzinga
  15. UPDATE: ISI Group Upgrades Cepheid

    Benzinga
  16. CEPHEID

    IBD
  17. LinkedIn, TripAdvisor, Google: Top Manager's Ideas

    IBD
  18. Alexion Takes Off On Outlook

    IBD
  19. Three Medical Tech Names To Watch In Healthcare Space

    IBD
  20. Align Leads Three Top-Rated Medical Equipment Stocks

    IBD
  21. UPDATE: JMP Securities Initiates Coverage on Cepheid on Market ...

    Benzinga
  22. Five Medical Stocks Leaders Trade Near New Highs

    IBD
  23. ViroPharma Gets Bought Out; Medicines Clears Entry

    IBD
  24. UPDATE: ISI Group Downgrades Cepheid on Key Drivers Constraining ...

    Benzinga
  25. Benzinga's Top Downgrades

    Benzinga
  26. UPDATE: Bank of America Downgrades Cepheid on Fair Valuation

    Benzinga
  27. Benzinga's Top Downgrades

    Benzinga
  28. Cepheid Reports Xpert MTB/RIF Categorized 'Moderate Complexity' ...

    Benzinga
  29. Cepheid Announces Board of Directors Changes

    Benzinga
  30. Cepheid's Chlamydia and N. Gonorrhoeae Test Categorized 'Moderate ...

    Benzinga
  31. Medtech Stocks Moving As Conference Makes Waves

    IBD
  32. Medtech Stocks Moving As Conference Makes Waves

    IBD
  33. Cepheid Offers Update on Xpert Test Availability, Sees Q4 Sales ...

    Benzinga
  34. UPDATE: Piper Jaffray Downgrades Cepheid to Neutral, Lowers PT

    Benzinga
  35. Oppenheimer Holdings Reiterates Outperform Rating, $43 PT on ...

    Benzinga
  36. Canaccord Genuity Reiterates Buy Rating, $50 PT on Cepheid

    Benzinga
  37. Cantor Fitzgerald Reiterates Hold Rating, $38 PT on Cepheid

    Benzinga
  38. US Stock Futures Down Ahead Of Economic Data

    Benzinga
  39. Stocks To Watch For December 28, 2012

    Benzinga
  40. UPDATE: Cepheid Wins FDA Clearance for Xpert CT/NG

    Benzinga
  41. UPDATE: Bank of America Initiates Cepheid at Buy on Prospects, ...

    Benzinga
  42. Look At That Base: If You Can't Name It, Don't Buy It

    IBD
  43. UPDATE: Goldman Sachs Downgrades Cepheid to Neutral on Lack of ...

    Benzinga
  44. Benzinga's Top Downgrades

    Benzinga
  45. Benzinga's Top Upgrades

    Benzinga
  46. CEPHEID Reports Operating Results (10-Q)

    GuruFocus
  47. UPDATE: Cantor Fitzgerald Maintains Cepheid at Hold on Analyst ...

    Benzinga
  48. UPDATE: Canaccord Genuity Reiterates Cepheid at Buy with $50 ...

    Benzinga
  49. Goldman Sachs Reiterates Buy Rating, $46 PT on Cepheid

    Benzinga
  50. UPDATE: ISI Group Reduces PT to $30.50 on Cepheid Post Analyst ...

    Benzinga
  51. Benzinga Mid-Afternoon Market Update

    Benzinga
  52. Stock Futures Point to Higher Open with Yahoo (YHOO) and Hewlett-Packard ...

    MarketIntelligenceCenter
  53. Benzinga Mid-Day Market Update

    Benzinga
  54. Mid-Morning Market Update

    Benzinga
  55. UPDATE: ISI Group Reduces PT to $32.50 on Cepheid Following Negative ...

    Benzinga
  56. Benzinga's Top Initiations

    Benzinga
  57. A Peek Into The Market Before The Trading Starts

    Benzinga
  58. UPDATE: JP Morgan Initiates Cepheid at Overweight on Growth Outlook

    Benzinga
  59. Benzinga's Top Initiations

    Benzinga
  60. Technology Sector Wrap

    FoxBusiness
  61. Technology Sector Wrap

    FoxBusiness
  62. Technology Sector Wrap

    FoxBusiness
  63. Analyst Downgrades: Cepheid, Intuitive Surgical, and Travelzoo

    SchaeffersResearch
  64. Cepheid Down 20% on Weak Guidance

    Benzinga
  65. CEPHEID (CPHD) CEO John L Bishop sells 40,201 Shares

    GuruFocus
  66. CEPHEID (CPHD) CEO John L Bishop sells 25,000 Shares

    GuruFocus
  67. CEPHEID (CPHD) EVP, CFO Andrew Miller sells 17,437 Shares

    GuruFocus
  68. A Peek Into The Market Before The Trading Starts

    Benzinga
  69. UPDATE: UBS Investment Research Upgrades Cepheid to Buy; Opportunistic ...

    Benzinga
  70. Benzinga's Top Downgrades With Color for May 14, 2012

    Benzinga
  71. UPDATE: GARP Research & Securities Downgrades Cepheid to Neutral; ...

    Benzinga
  72. Cepheid Earnings Miss Estimates; Stock Plummets

    IBD
  73. Cepheid Q1 Estimates Soft, But Outlook For Year Good

    IBD
  74. Zoll Deal, Intutive Surgical Lift Medical Equipment

    IBD
  75. Cepheid Stock Price Rises on Strong 2012 Sales Outlook

    IBD
  76. CEPHEID Reports Operating Results (10-K)

    GuruFocus
  77. CEPHEID (CPHD) EVP, CFO Andrew Miller sells 62,062 Shares

    GuruFocus
  78. CEPHEID (CPHD) CEO John L Bishop sells 6,887 Shares

    GuruFocus
  79. CEPHEID (CPHD) Executive VP, COO Humberto Reyes sells 133,957 ...

    GuruFocus
  80. Stocks Finish Week Split; Nasdaq, S&P 500 Higher

    IBD
  81. Stocks Stay Mixed; Under Armour Clears 50-Day

    IBD
  82. RBC Capital Upgrades Cepheid to Outperform

    Benzinga
  83. UPDATE: Credit Suisse Initiates Outperform, $40 Target on Cepheid

    Benzinga
  84. Analogic Earnings Preview: EPS Expected to Double

    Benzinga
Trading Center